BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15542413)

  • 1. Plasma brain natriuretic peptide levels in patients with rheumatic heart disease.
    Gölbaşý Z; Uçar O; Yüksel AG; Gülel O; Aydoğdu S; Ulusoy V
    Eur J Heart Fail; 2004 Oct; 6(6):757-60. PubMed ID: 15542413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of the reduction in B-type natriuretic peptide after mitral valve replacement in patients with rheumatic mitral stenosis.
    Leszek P; Klisiewicz A; Janas J; Różański J; Rywik T; Piotrowski W; Korewicki J
    Clin Physiol Funct Imaging; 2010 Nov; 30(6):473-9. PubMed ID: 20807228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum N-terminal brain natriuretic peptide indicates exercise induced augmentation of pulmonary artery pressure in patients with mitral stenosis.
    Kilickesmez KO; Ozkan AA; Abaci O; Camlıca H; Kocas C; Kaya A; Baskurt M; Yiğit Z; Kucukoğlu S
    Echocardiography; 2011 Jan; 28(1):8-14. PubMed ID: 20738368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation.
    Shang YP; Lai L; Chen J; Zhang F; Wang X
    J Heart Valve Dis; 2005 Jul; 14(4):453-9. PubMed ID: 16116870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
    Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
    J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal proBNP plasma levels correlate with severity of mitral stenosis.
    Iltumur K; Karabulut A; Yokus B; Yavuzkir M; Taskesen T; Toprak N
    J Heart Valve Dis; 2005 Nov; 14(6):735-41. PubMed ID: 16359052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma NT-proBNP is a potential marker of disease severity and correlates with symptoms in patients with chronic rheumatic valve disease.
    Davutoglu V; Celik A; Aksoy M; Sezen Y; Soydinc S; Gunay N
    Eur J Heart Fail; 2005 Jun; 7(4):532-6. PubMed ID: 15921791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of biomarkers in valvular heart disease: focus on natriuretic peptides.
    Bergler-Klein J; Gyöngyösi M; Maurer G
    Can J Cardiol; 2014 Sep; 30(9):1027-34. PubMed ID: 25151285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the level of plasma B-type natriuretic peptide and mitral stenosis.
    Eryol NK; Dogan A; Ozdogru I; Inanc MT; Kaya MG; Kalay N
    Int J Cardiovasc Imaging; 2007 Oct; 23(5):569-74. PubMed ID: 17186137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of the myocardial performance index with plasma B-type natriuretic peptide levels in patients with mitral regurgitation.
    Sayar N; Lütfullah Orhan A; Cakmak N; Yilmaz H; Atmaca H; Tangürek B; Hasdemir H; Nurkalem Z; Ergelen M; Aksu H; Yeşilçimen K
    Int J Cardiovasc Imaging; 2008 Feb; 24(2):151-7. PubMed ID: 17541723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy.
    Vanderheyden M; Goethals M; Verstreken S; De Bruyne B; Muller K; Van Schuerbeeck E; Bartunek J
    J Am Coll Cardiol; 2004 Dec; 44(12):2349-54. PubMed ID: 15607397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.
    Gerber IL; Stewart RA; Legget ME; West TM; French RL; Sutton TM; Yandle TG; French JK; Richards AM; White HD
    Circulation; 2003 Apr; 107(14):1884-90. PubMed ID: 12668523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and echocardiographic correlates of plasma B-type natriuretic peptide levels in patients with aortic valve stenosis and normal left ventricular ejection fraction.
    Maréchaux S; Hattabi M; Juthier F; Neicu DV; Richardson M; Carpentier E; Bouabdallaoui N; Delelis F; Banfi C; Breyne J; Jude B; Asseman P; Vincentelli A; Le Tourneau T; Graux P; Pibarot P; Ennezat PV
    Echocardiography; 2011 Aug; 28(7):695-702. PubMed ID: 21564276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is measurement of plasma brain natriuretic peptide levels a useful test to detect for surgical timing of valve disease?
    Watanabe M; Murakami M; Furukawa H; Nakahara H
    Int J Cardiol; 2004 Jul; 96(1):21-4. PubMed ID: 15203256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT dispersion in patients with rheumatic mitral stenosis and its relation with echocardiographic findings and serum NT-proBNP levels.
    Kılıçkesmez KO; Bulut G; Başkurt M; Coşkun U; Yıldız A; Küçükoğlu S
    Turk Kardiyol Dern Ars; 2011 Apr; 39(3):183-90. PubMed ID: 21532293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between B-natriuretic peptide and hemodynamics in patients with decompensated heart failure and clinical significance].
    Zhao SQ; Li Q; Wu T; Liu XR; Zhao N; Nie XL; Wang M; Hu YM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jun; 33(6):502-4. PubMed ID: 16053780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valvular heart disease: plasma B-type natriuretic peptide levels in patients with pure rheumatic mitral stenosis.
    Uçar O; Bayar N; Karagöz A; Aydoğdu S
    Acta Cardiol; 2012 Feb; 67(1):59-64. PubMed ID: 22455090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of B-type natriuretic peptide activation to left ventricular end-systolic remodeling in organic and functional mitral regurgitation.
    Detaint D; Messika-Zeitoun D; Chen HH; Rossi A; Avierinos JF; Scott C; Burnett JC; Enriquez-Sarano M
    Am J Cardiol; 2006 Apr; 97(7):1029-34. PubMed ID: 16563910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
    López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
    Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.